Sunita D. Srivastava, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 18 | 2023 | 1348 | 1.830 |
Why?
|
| Aortic Aneurysm, Abdominal | 12 | 2023 | 1149 | 1.250 |
Why?
|
| Endovascular Procedures | 8 | 2023 | 1936 | 1.010 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 152 | 0.730 |
Why?
|
| Authorship | 1 | 2022 | 278 | 0.640 |
Why?
|
| Physicians, Women | 2 | 2022 | 494 | 0.640 |
Why?
|
| Blood Vessel Prosthesis | 7 | 2022 | 916 | 0.510 |
Why?
|
| Aneurysm | 3 | 2013 | 335 | 0.440 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2023 | 536 | 0.410 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1413 | 0.370 |
Why?
|
| Viscera | 1 | 2010 | 136 | 0.360 |
Why?
|
| Vascular Surgical Procedures | 5 | 2011 | 1425 | 0.350 |
Why?
|
| Carotid Artery Diseases | 2 | 2011 | 857 | 0.290 |
Why?
|
| Biomedical Research | 1 | 2022 | 3270 | 0.270 |
Why?
|
| Vascular Patency | 6 | 2023 | 877 | 0.260 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 506 | 0.250 |
Why?
|
| Endoleak | 3 | 2015 | 101 | 0.250 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 652 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 1250 | 0.230 |
Why?
|
| Urinary Retention | 1 | 2023 | 108 | 0.210 |
Why?
|
| Stents | 10 | 2011 | 3193 | 0.210 |
Why?
|
| Diverticulum | 1 | 2021 | 131 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2013 | 4598 | 0.180 |
Why?
|
| Device Removal | 2 | 2015 | 619 | 0.170 |
Why?
|
| Retrospective Studies | 17 | 2023 | 76887 | 0.170 |
Why?
|
| Prosthesis Design | 4 | 2022 | 2096 | 0.170 |
Why?
|
| Angioplasty, Balloon | 3 | 2009 | 610 | 0.160 |
Why?
|
| Endarterectomy, Carotid | 1 | 2023 | 538 | 0.150 |
Why?
|
| Treatment Outcome | 16 | 2023 | 62430 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 860 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 437 | 0.150 |
Why?
|
| Chordoma | 1 | 2020 | 352 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2013 | 1204 | 0.140 |
Why?
|
| Aortic Aneurysm | 2 | 2015 | 630 | 0.140 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 240 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2024 | 1029 | 0.140 |
Why?
|
| Free Tissue Flaps | 1 | 2020 | 329 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 2944 | 0.130 |
Why?
|
| Bone Transplantation | 1 | 2020 | 901 | 0.130 |
Why?
|
| Iliac Artery | 2 | 2009 | 355 | 0.130 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 697 | 0.110 |
Why?
|
| Risk Factors | 10 | 2023 | 70952 | 0.110 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2009 | 751 | 0.110 |
Why?
|
| After-Hours Care | 1 | 2013 | 99 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1125 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1058 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2004 | 595 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 3 | 2011 | 424 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1809 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 2475 | 0.090 |
Why?
|
| Splenic Artery | 1 | 2011 | 58 | 0.090 |
Why?
|
| Aged | 18 | 2023 | 161495 | 0.090 |
Why?
|
| Emergencies | 2 | 2013 | 1138 | 0.090 |
Why?
|
| Life Tables | 1 | 2010 | 369 | 0.090 |
Why?
|
| Collateral Circulation | 1 | 2010 | 272 | 0.090 |
Why?
|
| Humans | 35 | 2024 | 735458 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2023 | 3034 | 0.080 |
Why?
|
| Angiography | 3 | 2023 | 1601 | 0.080 |
Why?
|
| Sex Factors | 2 | 2022 | 10157 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 258 | 0.080 |
Why?
|
| Carotid Artery, Internal | 1 | 2011 | 426 | 0.080 |
Why?
|
| Postoperative Complications | 7 | 2023 | 15156 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2013 | 6365 | 0.080 |
Why?
|
| Female | 20 | 2023 | 376708 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3157 | 0.070 |
Why?
|
| Ohio | 3 | 2013 | 329 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1495 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 494 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2006 | 57 | 0.070 |
Why?
|
| Aortography | 3 | 2015 | 418 | 0.070 |
Why?
|
| Time Factors | 12 | 2015 | 39212 | 0.070 |
Why?
|
| Inguinal Canal | 1 | 2006 | 69 | 0.070 |
Why?
|
| Foreign-Body Migration | 2 | 2004 | 214 | 0.060 |
Why?
|
| Male | 21 | 2024 | 346169 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1444 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4577 | 0.060 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 93 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 457 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8197 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2009 | 694 | 0.060 |
Why?
|
| Robotics | 1 | 2010 | 884 | 0.050 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2003 | 43 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2006 | 870 | 0.050 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2003 | 36 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 629 | 0.050 |
Why?
|
| Renal Artery | 1 | 2004 | 370 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 56770 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1183 | 0.050 |
Why?
|
| Reoperation | 5 | 2013 | 4209 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 127 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 19878 | 0.050 |
Why?
|
| Angioplasty | 1 | 2003 | 352 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2020 | 5702 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 1995 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 2016 | 0.040 |
Why?
|
| Warfarin | 1 | 2008 | 1479 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 2021 | 527 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6364 | 0.040 |
Why?
|
| Portal Vein | 1 | 2020 | 428 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 2008 | 0.040 |
Why?
|
| Radiography | 2 | 2004 | 6932 | 0.030 |
Why?
|
| Middle Aged | 14 | 2020 | 211305 | 0.030 |
Why?
|
| Aspirin | 1 | 2008 | 3209 | 0.030 |
Why?
|
| United States | 2 | 2023 | 69005 | 0.030 |
Why?
|
| Length of Stay | 2 | 2023 | 6216 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2021 | 1036 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2975 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 1992 | 0.030 |
Why?
|
| Ischemia | 1 | 2021 | 1836 | 0.030 |
Why?
|
| Equipment Safety | 2 | 2003 | 260 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2694 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 1934 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 212371 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3666 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 542 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2592 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2003 | 10060 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 38356 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 13117 | 0.020 |
Why?
|
| Michigan | 1 | 2006 | 335 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2004 | 43 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3404 | 0.020 |
Why?
|
| Iliac Aneurysm | 1 | 2004 | 36 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2006 | 558 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 116 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 233 | 0.010 |
Why?
|
| Health Care Sector | 1 | 2004 | 192 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 979 | 0.010 |
Why?
|
| Biomedical Technology | 1 | 2004 | 210 | 0.010 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 270 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2004 | 557 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 619 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1418 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5109 | 0.010 |
Why?
|
| Thrombosis | 1 | 2013 | 2928 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13734 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1456 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12113 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35374 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1813 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8232 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4593 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 1423 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5879 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6213 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3499 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 9009 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14147 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 11939 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 22901 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12513 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 21329 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 14815 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15306 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 79548 | 0.000 |
Why?
|
| Animals | 1 | 2006 | 165479 | 0.000 |
Why?
|